Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CCDC160 | Human | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of CCDC160 mRNA | CTD | PMID:29581250 | CCDC160 | Human | 4,4'-sulfonyldiphenol | increases methylation | ISO | Ccdc160 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of CCDC160 exon | CTD | PMID:33297965 | CCDC160 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CCDC160 mRNA | CTD | PMID:21934132 | CCDC160 | Human | all-trans-retinoic acid | multiple interactions | ISO | Ccdc160 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CCDC160 mRNA | CTD | PMID:36189433 | CCDC160 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of CCDC160 promoter | CTD | PMID:27901495 | CCDC160 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of CCDC160 5' UTR | CTD | PMID:27901495 | CCDC160 | Human | bisphenol A | affects expression | ISO | Ccdc160 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of CCDC160 mRNA | CTD | PMID:25181051 | CCDC160 | Human | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of CCDC160 mRNA | CTD | PMID:26079696 | CCDC160 | Human | carbon nanotube | decreases expression | ISO | Ccdc160 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of CCDC160 mRNA | CTD | PMID:25554681 | CCDC160 | Human | chlordecone | multiple interactions | ISO | Ccdc160 (Mus musculus) | 6480464 | Chlordecone promotes the reaction [Biomarkers metabolite binds to CCDC160 gene] | CTD | PMID:31084621 | CCDC160 | Human | gentamycin | decreases expression | ISO | Ccdc160 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of CCDC160 mRNA | CTD | PMID:33387578 | CCDC160 | Human | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Ccdc160 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CCDC160 mRNA | CTD | PMID:36189433 | CCDC160 | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of CCDC160 mRNA | CTD | PMID:25583101 | CCDC160 | Human | pentanal | increases expression | EXP | | 6480464 | pentanal results in increased expression of CCDC160 mRNA | CTD | PMID:26079696 | CCDC160 | Human | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CCDC160 mRNA | CTD | PMID:19710929 | CCDC160 | Human | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of CCDC160 mRNA | CTD | PMID:26079696 | CCDC160 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of CCDC160 mRNA | CTD | PMID:31533062 | CCDC160 | Human | titanium dioxide | decreases expression | ISO | Ccdc160 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of CCDC160 mRNA | CTD | PMID:29264374 | CCDC160 | Human | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of CCDC160 mRNA | CTD | PMID:30510588 | CCDC160 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of CCDC160 gene | CTD | PMID:29154799 | CCDC160 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CCDC160 mRNA | CTD | PMID:28001369 | |